Role of transcutaneous CO2 monitoring in high-risk respiratory patients
października 16, 2013
Presented by Gil De Oliveira, MD
"The Role of Transcutaneous CO2 Monitoring in High Risk Respiratory Patients"
Speaker: Gil De Oliveira, MD
Associate Chair for research at the department of anesthesiology at Northwestern University and associate attending at Northwestern Memorial Hospital in Chicago.
Editor-in-chief for the Journal of Ambulatory Anesthesia
Member of the American Society of Anesthesiology
Member of the Society of Ambulatory Anesthesia
Member of the Society of ambulatory anesthesia committee.
All clinicians understand that disasters are more likely to be averted when trends are detected early. This is especially true when caring for the varied cross-section of patients who hypo/hyperventilate. Thanks to dramatic advances in the speed and accuracy of the purely non-invasive transcutaneous CO2 measurement (TcCO2), serious respiratory events can be predicted more dependably than ever before.
For this reason, accurate CO2 trending is critical to a number of clinical specialties including respiratory therapists, intensivists, general internists, anesthesiologists, pulmonologists, emergency physicians, palliative medicine caregivers, neonatal specialists, plastic surgeons, and dental surgeons.
Dr. Oliveira will define impending respiratory complications and offer diagnostic guidelines for its proper diagnosis. He will identify those patients at high risk of respiratory failure and suggest strategies to increase their safety. He will explain the physiologic derangements in high-risk respiratory patients, and describe the role of pulse oximetry to monitor them.
As a result of improved TcCO2 trend detection, patients with sleep apnea, those on high-dose pain medication, and post-op, ICU, and PICU/NICU patients stand a greater chance of avoiding respiratory disasters, especially when compared to using the older nasal end-tidal CO2 (EtCO2) method of measurement.